Echocardiographic Improvement Over Time After Cessation of Use of Fenfluramine and Phentermine
- 1 December 1999
- journal article
- clinical trial
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 74 (12), 1191-1197
- https://doi.org/10.4065/74.12.1191
Abstract
No abstract availableKeywords
Funding Information
- Mayo Foundation for Medical Education and Research
- U.S. Public Health Service
This publication has 12 references indexed in Scilit:
- Serial Echocardiographic and Clinical Evaluation of Valvular Regurgitation Before, During, and After Treatment with Fenfluramine or Dexfenfluramine and Mazindol or PhentermineObesity Research, 1999
- Risk for Valvular Heart Disease among Users of Fenfluramine and Dexfenfluramine Who Underwent Echocardiography before Use of MedicationAnnals of Internal Medicine, 1998
- An Assessment of Heart-Valve Abnormalities in Obese Patients Taking Dexfenfluramine, Sustained-Release Dexfenfluramine, or PlaceboNew England Journal of Medicine, 1998
- A Population-Based Study of Appetite-Suppressant Drugs and the Risk of Cardiac-Valve RegurgitationNew England Journal of Medicine, 1998
- The Prevalence of Cardiac Valvular Insufficiency Assessed by Transthoracic Echocardiography in Obese Patients Treated with Appetite-Suppressant DrugsNew England Journal of Medicine, 1998
- Further Cases of Valvular Heart Disease Associated with Fenfluramine–PhentermineNew England Journal of Medicine, 1997
- Valvular Heart Disease Associated with Fenfluramine–PhentermineNew England Journal of Medicine, 1997
- Evaluation of aortic insufficiency by Doppler color flow mappingJournal of the American College of Cardiology, 1987
- Color Doppler assessment of mitral regurgitation with orthogonal planes.Circulation, 1987
- Doppler Echocardiography: Theory, Instrumentation, Technique, and ApplicationMayo Clinic Proceedings, 1985